EYPT
Price
$7.24
Change
+$0.03 (+0.42%)
Updated
May 30 closing price
Capitalization
498.2M
59 days until earnings call
FBIO
Price
$1.89
Change
-$0.06 (-3.08%)
Updated
May 30 closing price
Capitalization
55.3M
Interact to see
Advertisement

EYPT vs FBIO

Header iconEYPT vs FBIO Comparison
Open Charts EYPT vs FBIOBanner chart's image
EyePoint Pharmaceuticals
Price$7.24
Change+$0.03 (+0.42%)
Volume$2.15M
Capitalization498.2M
Fortress Biotech
Price$1.89
Change-$0.06 (-3.08%)
Volume$110.29K
Capitalization55.3M
EYPT vs FBIO Comparison Chart
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. FBIO commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and FBIO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (EYPT: $7.24 vs. FBIO: $1.89)
Brand notoriety: EYPT and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 263% vs. FBIO: 62%
Market capitalization -- EYPT: $498.2M vs. FBIO: $55.3M
EYPT [@Biotechnology] is valued at $498.2M. FBIO’s [@Biotechnology] market capitalization is $55.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileFBIO’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • FBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIO is a better buy in the long-term than EYPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 6 TA indicator(s) are bullish while FBIO’s TA Score has 6 bullish TA indicator(s).

  • EYPT’s TA Score: 6 bullish, 4 bearish.
  • FBIO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both EYPT and FBIO are a good buy in the short-term.

Price Growth

EYPT (@Biotechnology) experienced а +27.46% price change this week, while FBIO (@Biotechnology) price change was +6.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

FBIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($498M) has a higher market cap than FBIO($55.3M). EYPT YTD gains are higher at: -2.819 vs. FBIO (-6.667). FBIO has higher annual earnings (EBITDA): -108.52M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. FBIO (58.9M). EYPT has less debt than FBIO: EYPT (24.1M) vs FBIO (71.5M). FBIO has higher revenues than EYPT: FBIO (62.5M) vs EYPT (56M).
EYPTFBIOEYPT / FBIO
Capitalization498M55.3M901%
EBITDA-144.55M-108.52M133%
Gain YTD-2.819-6.66742%
P/E RatioN/AN/A-
Revenue56M62.5M90%
Total Cash318M58.9M540%
Total Debt24.1M71.5M34%
FUNDAMENTALS RATINGS
EYPT vs FBIO: Fundamental Ratings
EYPT
FBIO
OUTLOOK RATING
1..100
4225
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
5749
P/E GROWTH RATING
1..100
16100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (36) in the Biotechnology industry is in the same range as EYPT (59) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew similarly to EYPT’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EYPT (100) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as FBIO (98) in the Biotechnology industry. This means that EYPT’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's Price Growth Rating (49) in the Biotechnology industry is in the same range as EYPT (57) in the Pharmaceuticals Major industry. This means that FBIO’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's P/E Growth Rating (16) in the Pharmaceuticals Major industry is significantly better than the same rating for FBIO (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than FBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTFBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSAFX9.990.01
+0.10%
Hussman Strategic Allocation
MSRRX54.86-0.02
-0.04%
MFS Research R2
CSSJX24.29-0.01
-0.04%
Carillon Chartwell Small Cap C
JIGZX78.60-0.23
-0.29%
JPMorgan U.S. GARP Equity R2
DCUIX13.38-0.05
-0.37%
DWS CROCI US Inst

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.42%
OCUL - EYPT
59%
Loosely correlated
-1.60%
LYRA - EYPT
58%
Loosely correlated
-1.60%
ATHE - EYPT
54%
Loosely correlated
-3.02%
BEAM - EYPT
54%
Loosely correlated
-3.00%
RXRX - EYPT
53%
Loosely correlated
-6.07%
More

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with CRBP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
-3.08%
CRBP - FBIO
38%
Loosely correlated
-2.62%
AXON - FBIO
38%
Loosely correlated
+2.75%
ABOS - FBIO
35%
Loosely correlated
-2.86%
EYPT - FBIO
34%
Loosely correlated
+0.42%
KYTX - FBIO
33%
Poorly correlated
-3.04%
More